Resmed (RMD) Cash from Investing Activities (2009 - 2026)
Resmed (RMD) posted Cash from Investing Activities of -$58.0 million for Q1 2026, down 13.91% on a QoQ basis from -$50.9 million in Q4 2025, and down 82.56% year-over-year from -$332.7 million in Q1 2025.
Resmed (RMD) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Resmed's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$58.0 million for Q1 2026.
- Quarterly Cash from Investing Activities fell 82.56% year-over-year to -$58.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$295.3 million (down 161.66% YoY) and the FY2025 annual result came in at -$200.0 million, up 25.85% from the prior year.
- Cash from Investing Activities was -$58.0 million for Q1 2026 at Resmed, down from -$50.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $2.1 million in Q3 2024 and bottomed at -$1.0 billion in Q4 2022.
- A 5-year average of -$111.5 million and a median of -$49.5 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 101.44% — and 2025, when it plunged 2550.05%.
- Resmed's Cash from Investing Activities stood at -$1.0 billion in 2022, then soared by 95.99% to -$41.1 million in 2023, then advanced by 10.82% to -$36.7 million in 2024, then sank by 38.84% to -$50.9 million in 2025, then fell by 13.91% to -$58.0 million in 2026.
- Business Quant data shows RMD's Cash from Investing Activities at -$58.0 million in Q1 2026, -$50.9 million in Q4 2025, and -$52.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.03 Mn |
| Mar 31, 2026 | -58.03 Mn |
| Dec 31, 2025 | -50.94 Mn |
| Dec 31, 2025 | -50.94 Mn |
| Sep 30, 2025 | -52.58 Mn |
| Sep 30, 2025 | -52.58 Mn |
| Jun 30, 2025 | -133.71 Mn |
| Jun 30, 2025 | -133.71 Mn |
| Mar 31, 2025 | -31.79 Mn |
| Mar 31, 2025 | -31.79 Mn |
| Dec 31, 2024 | -36.69 Mn |
| Dec 31, 2024 | -36.69 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | -46.51 Mn |
| Jun 30, 2024 | -46.51 Mn |
| Mar 31, 2024 | -33.15 Mn |
| Mar 31, 2024 | -33.15 Mn |
| Dec 31, 2023 | -41.14 Mn |
| Dec 31, 2023 | -41.14 Mn |